Zeto Received New Therapy Commercialization Award from Epilepsy Foundation

In Dec 2017, ZETO won an investment of $200,000 from the Epilepsy Foundation as part of its New Therapy Commercialization Award Program.

We feel honored to have the Epilepsy Foundation on board as an investor. This investment is a testimonial to their belief and commitment to ZETO and we look forward to working with them in commercializing our product.